Introduction and Aims. To estimate the prevalence and frequency of amphetamine use in a cohort of Australians aged in their mid-30s. Design and Methods. Cross-sectional analysis of wave 10 data collected in 2014 from the Victorian Adolescent Health Cohort Study: a sample of 1435 persons originally selected in a stratified, random community survey of secondary school students from the state of Victoria that commenced in 1992. Weighted multinomial regression models were used to evaluate the social, health and other substance-use correlates of lifetime and current (12-month) amphetamine use and current frequency of use. Results. Lifetime amphetamine use was reported by 23.2% (95% confidence interval 21.0-25.5%) of respondents, and 6.5% (95% confidence interval 5.2-7.8%) reported current (12-month) use. A quarter (26%) of those currently using amphetamines, 1.7% (95% confidence interval 1.0-2.4%) of all respondents, reported frequent (at least weekly) use. Men reported greater amphetamine use than women. Current amphetamine use was associated with disrupted family circumstances, socioeconomic adversity, polydrug use and high levels of drug use within the social and familial environment. Frequent use was associated with greater likelihood of multiple adversity, unemployment, anxiety disorders and use of mental health services. Discussion and Conclusions. The current results show that lifetime, current and frequent amphetamine use was common amongst adults in the fourth decade of life in this cohort, and associated with the experience of social disadvantage, poor mental health and living in a social context in which drug use is the norm. 
Introduction
Amphetamines are one of the most commonly used illicit drugs in Australia and internationally [1] [2] [3] . Data from the National Drug Strategy Household Surveys (NDSHS; [1] ) suggest overall amphetamine use in Australia has declined since the late 1990s but people currently using amphetamines are doing so more frequently than in the past: a change that coincides with crystal methamphetamine becoming the main form of amphetamine used in Australia [4, 5] . Surveys and administrative data often do not differentiate between the different types of amphetamines. In such circumstances, some authors use the term 'methamphetamine' and the NDSHS has used the term 'meth/ amphetamine' [6] . In this paper, we use the term 'amphetamine' to reference the broader class of drug. However, we recognise that contemporary amphetamine use in Australia largely reflects methamphetamine use, particularly when the focus is on frequent or regular use.
While the NDSHS is the leading survey of drug use in Australia and provides a regular national snapshot of drug use, attitudes and correlates, concerns have been expressed about the validity of estimates of illicit drug use based on cross-sectional household surveys.
For example, it has been argued that low response rates (only 33% of eligible households completed the NDSHS) can limit generalisability [1] , that respondents may under-report drug use due to concerns about illegality or stigma [7] , and that the household sampling frame of the NDSHS excludes many heavy users of illicit drugs [8] .
Nonetheless, other evidence supports the conclusion that there has been an increase over time in frequent methamphetamine use in Australia, including data on drug seizures, hospital separations, mental health admissions, arrests, treatment episodes, ambulance attendances, wastewater analysis and calls to telephone helplines [5, [7] [8] [9] [10] [11] [12] . Indirect prevalence estimates of methamphetamine use, although controversial [13] , have been derived using data on amphetamine-related hospital separations and data on treatment episodes for amphetamine use from the National Minimum Data Set for Alcohol and Other Drug Treatment Services. These indirect estimates also show increasing levels of regular/frequent methamphetamine use, rising to 2.09% in 2013-2014, and with the highest prevalence amongst people aged 25 to 34 years [8] .
There is increasing community concern in Australia about the harms and adverse consequences of methamphetamine use, reflected in intense media attention [14] . A recent report estimated the broad social costs of methamphetamine use in Australia in 2013-2014 (incorporating costs associated with prevention, treatment, healthcare, criminal justice and economic impacts) at over $5 billion [6] . In part, these estimates were based on NDSHS and other surveys, and, therefore, potentially subject to the same limitations discussed above.
The current paper uses a different data source to estimate the prevalence and correlates of contemporary amphetamine use in Australia. It uses data from the most recent wave of the Victorian Adolescent Health Cohort Study (VAHCS). This study has followed a community cohort of Victorian high school students for over 20 years. As a consequence of the robust sampling frame, the high initial participation rate, and the low attrition over time, the VAHCS sample is welldefined and is less affected by the non-response and attrition biases that constrain other survey data. Further, the engagement of cohort members in the survey for over 20 years is likely to have led to panel conditioning [15, 16] , which refers to how repeated participation in a longitudinal survey may influence responses. While panel conditioning can be a source of bias, it can also potentially increase the validity and accuracy of survey responses over time. The long-term engagement of participants in the VAHCS could, for example, increase their trust and confidence in the project staff and their commitment to the study. This may reduce the potential social desirability bias to sensitive questions about substance use. This would improve the accuracy of participant responses relative to a stand-alone cross-sectional survey.
Our primary aims, therefore, are to estimate the prevalence and frequency of amphetamine use in the VAHCS cohort, and to benchmark these findings against previously published estimates. Importantly, cohort members are in the age range with the highest rates of methamphetamine use [8] , increasing the policy relevance of the findings. In addition, we will draw upon the rich array of data collected through the VAHCS to identify the social, health and other substance-use correlates of amphetamine use to characterise those who are using amphetamines in contemporary Australia.
Methods
Study design and participants: Participants in the VAHCS were aged 14 or 15 years when the study commenced. The VAHCS was designed as a representative sample of Victorian mid-secondary-school aged adolescents in 1992. The student population closely resembled the overall population of adolescents in this age range (i.e. the school retention rate to year 9 in 1992 was 98%). The study used a two-stage cluster sampling approach, with 45 Victorian high schools selected from a state-wide (metropolitan and regional) stratified frame of government, Catholic and independent schools, with the probability of selection proportional to student numbers. One Year 9 class was randomly selected from each sampled school to participate in the wave 1 assessment in the second half of 1992. One school did not continue beyond wave one, with the loss of 13 respondents. For the remaining 44 schools, a second (now year 10) class commenced assessment at the second time point (early in 1993).
The total potential sample of the VAHCS was 2032 (1037 students in the classes recruited in 1992 and 994 in the 1993 classes). Four further (6-monthly) assessments occurred during adolescence, and 96% of the intended sample (n = 1943) participated in at least one of these adolescent assessments. Cohort members were also assessed on three occasions during their 20s, and 86.7% of the sample participated in at least one adult assessment (see Figure 1) .
The current paper reports analysis of the latest (tenth) wave of data collection from 2014, when sample participants were, on average, 35.1 years (standard deviation [SD] = 0.6 years). Comparison with weighted estimates from age-matched respondents in the 2014 wave of the national Household Income and Labour Dynamics in Australia (HILDA) survey [17] shows the broad representativeness of the VAHCS (e.g. unemployed: VAHCS 3.9%, HILDA 3.6%; university education: VAHCS 50.0%, HILDA 52.9%; married/de facto relationship >2 years: VAHCS 67.8%, HILDA 67.7%).
Most participants were assessed via computerassisted telephone interviews (CATI: 93%), with the remainder completing the survey online. A small subset of respondents (balanced across the CATI and online conditions) undertook an abbreviated survey (6.6%). Further detail of study design and methods is available elsewhere [18] .
From the original total potential sample of 2032 students, 1443 were re-interviewed at wave 10 (74.3% of those who provided data during adolescence and 81.1% of those who had participated as an adult). Adult respondents have provided written informed consent prior to each wave. The Ethics in Human Research Committee of the Royal Children's Hospital, Melbourne approved the study (HREC 21009).
Measures
Participants' amphetamine use status was classified based on three questions assessing non-medicinal use of amphetamines (and using the street terms speed, goey, crystal meth, ice, uppers): (i) ever; (ii) in the past year (described in this analysis as current use); and (iii) the maximal frequency of use in the past year (almost every day, 3/4 days/week, 1/2 days/week, 1/3 days/month, or < 1/month). No respondent selected the 1/3 days/month category. For analysis, current (12-month) use was categorised as none, infrequent (less than monthly), and frequent (weekly or more often). Dependence was assessed using the Severity of Dependence Scale [19] .
The survey assessed current marital/relationship status, history of divorce/separation, employment status, having children, living alone, educational attainment and receipt of government pensions/payments (see Table 2 for details). A measure of multiple social disadvantage was calculated.
Respondents were asked whether they had experienced a major physical illness in the past year. The 12-month prevalence of Major Depression Disorder and anxiety disorders (Generalised Anxiety Disorder, Social Phobia, Panic Disorder) was assessed using the Composite International Diagnostic Interview: a structured diagnostic survey instrument that assessed International Classification of Diseases (10th revision) criteria [20] . A single item assessed 12-month mental health service use.
Current (past month) smoking status was assessed by a single item. A (retrospective) alcohol consumption diary was used to estimate high short-term alcohol risk according to National Health and Medical Research Council guidelines [21, 22] . Single items assessed 12-month use of cannabis, cocaine and ecstasy and the Composite International Diagnostic Interview was used to generate 12-month prevalence estimates of Alcohol and Cannabis Dependence. A series of items asked respondents whether their friends used alcohol, tobacco or cannabis daily/nearly daily, and whether their partner used alcohol, tobacco or cannabis 5 or more days/week or had used other drugs in the past year.
Statistical analyses
Sample weights were calculated to adjust for the probability of non-participation in the wave 10 interview. A set of variables drawn from the original sampling frame (e.g. school, school type and region) and respondent characteristics from their earliest adolescent assessment (e.g. gender, smoking status and parental divorce) were used to predict wave 10 participation and generate inverse probability weights to correct for potential attrition bias (region and parental divorce did not contribute to the final model). We could adjust for Prevalence and correlates of amphetamine useattrition amongst the 96% of the in-scope population who participated in an adolescent assessment. This paper presents weighted estimates and model results. The weighted results show a slightly greater level of current (6.5% vs. 6.3%) and prior (16.7% vs. 16.2%) amphetamine use than the unweighted analyses. These differences are minimal and there was no difference in patterns or magnitude of significance.
While missing data were relatively rare for respondents who answered the full survey (with only 0.5% of observations for variables analysed in the current study missing),18 variables included in the analyses were not included in the short-form survey and had between 6.5% and 8.5% missing data. Compared to those who completed the full assessment, respondents who completed the abbreviated survey were more likely to have previously (but not currently) used amphetamines (univariable logistic regression model odds ratio [OR] = 1.6, 95% confidence interval [CI] 1.0-2.5), and to report vocational qualifications (2.4, 95% CI 1.5-3.9) or incomplete high school (3.0, 95% CI 1.3-6.8).
To address missing data, multiple imputation using chained equations was used to generate 50 imputed datasets. The imputation model included all analysis variables, four variables associated with attrition (parental divorce, smoking at entry to study, school and school region), and the wave nine variables corresponding with each wave 10 variable. The imputation sample comprised all wave 10 respondents with data on past year amphetamine use (n = 1435). Partner substance-use data was only imputed for respondents who reported that they were in a relationship (imputation sample for partner items was 1152). Amphetamine dependence was not imputed given the low prevalence (0.5%). Ordinal variables were imputed by ordered logistic regression and binary variables using logistic regression. We obtained the final estimates by averaging results across the imputed datasets using Rubin's rules for multiple imputation inference [23] . This paper reports the imputed results, but there was no difference in the results or pattern of significance in complete case analysis.
Descriptive statistics on prevalence and frequency of amphetamine use are reported by sex. A series of multinomial regression models regressed categories of amphetamine use (never, prior or current) onto each of the social, health and other substance-use measures, controlling for sex. A subsequent set of models (reported in text) evaluated characteristics that differentiated frequent and infrequent current use. Finally, a parsimonious multivariable multinomial model was developed to identify the significant independent correlates of amphetamine use (not considering the peer or partner substance-use variables). A standard approach to model building was employed with variables with a univariable P ≤ 0.2 included in a preliminary multivariable model. Backward elimination was then used to remove variables that did not meet criteria of P < 0.05 without resulting in poorer model fit (evaluated by comparing model log-likelihood statistics). Data analysis was conducted using STATA 14:1.
Results
Overall, 23.2% (95% CI 21.0-25.5%) of respondents reported lifetime use of amphetamines: 6.5% (95% CI 5.2-7.8%) were identified as currently using amphetamines (i.e. use in the past 12 months) and 16.7% (95% CI 14.7-18.7%) reported lifetime but not current use. Only seven respondents (7.7% of current users) were likely to be amphetamine dependent. In total, 1.7% (95% CI 1.0-2.4%) of all respondents (or 26% of those currently using amphetamines) reported frequent use. Men were more likely than women to report prior, current and frequent amphetamine use (see Table 1 ).
Past and current amphetamine use were both associated with a history of divorce/separation and financial hardship, and current (but not prior) use was associated with unemployment, living alone and vocational or year 12 (vs. tertiary) levels of educational attainment (see Table 2 ). There was a strong gradient (current > prior > never use) evident in having no current partner, having no children, and reporting multiple disadvantage. Further analysis (not reported in Table 2) showed that, amongst people who were currently using amphetamines, multiple disadvantage (OR = 4.24, 95% CI 1.36-13.19) was associated with increased likelihood of frequent (vs. infrequent) amphetamine use. There was evidence of a similar (though non-significant) pattern for unemployment (OR = 4.03, 95% CI 0.88-18.48) and receipt of government benefits (OR = 4.15, 95% CI 0.83-20.78). Table 2 also shows that people who reported anxiety or depressive disorders, or mental health service use were at increased risk of current amphetamine use, with a weaker but still significantly elevated risk of prior (vs. never) amphetamine use. Further analysis (not reported in Table 3 ) showed that people who reported an anxiety disorder (OR = 4.08, 95% CI 1.23-13.58) or mental health service use (OR = 3.99, 95% CI 1.34-11.84) were more likely to be identified as frequent current users (weekly+).
Measures of other drug use/dependence were the strongest correlates of amphetamine use (Table 3) . Smoking, risky alcohol consumption, 12-month use of cannabis, cocaine and ecstasy, and cannabis and a Proportions and associations were estimated using inverse probability weights to account for attrition prior to age 35. Multiple imputation was used to handle missing items within age 35 survey. CI, confidence interval; RRR, relative risk ratio. alcohol dependence were all associated with current and, to a lesser extent, prior amphetamine use. The majority of people currently using amphetamines were current smokers (54%), used alcohol at high-risk levels (62%) and used cannabis (63%), while their rates of past year cocaine (48%) and ecstasy use (38%) were high. Peer alcohol, tobacco and cannabis use were also associated with increased likelihood of current (and prior) amphetamine use. Amongst VAHCS participants with a partner, their partner's tobacco, cannabis and other drug use were associated with their own current use of amphetamines. Additional analysis found that no evidence that own, peer or partner substance use were associated with frequency of current amphetamine use.
The final multivariable multinomial model (Table 4) showed that depression and other substance use (smoking, cannabis, cocaine and ecstasy), being male and having a vocational or Year 12 only educational background, were each independently associated with increased likelihood of current amphetamine use.
Discussion
Almost one in four (23.2%) VAHCS respondents reported lifetime amphetamine use and 6.5% were identified as currently (in the past 12 months) using amphetamines. A quarter (26%) of these current users (or 1.7% of all respondents) were using amphetamines weekly or more often. These figures are much greater than the published NDSHS estimates which report that 3.1% of 30-39-year-old Australians had used amphetamines in the past year, and only 15.3% of those using amphetamines in the past year (<0.5% of a Proportions and associations were estimated using inverse probability weights to account for attrition prior to age 35. Multiple imputation was used to handle missing items within age 35 survey. b Partner questions not answered by 283 participants who were not in a relationship. Partner items were not imputed for these participants. CI, confidence interval; RRR, relative risk ratio.
30-39-year-old Australians) were using amphetamines weekly or more frequently. Our results suggest that amphetamine use is much more common among adults in the fourth decade of life in contemporary Australia than suggested by household surveys.
These differences cannot be attributed to flaws in the VAHCS design. The sample was randomly drawn from the population of Victorian high school students and early waves demonstrated a very high participation rate. Further, sample weights were generated using information on the schools recruited to the study and respondents themselves (including early adolescent smoking) to adjust for attrition over time and minimise potential bias. While the estimate of current (12-month) amphetamine use is more than double that based on the NDSHS, this magnitude of difference is not evident for other, less-stigmatised illicit drugs. For example, the VAHCS estimate of current cannabis use (14.3%, 95% CI 12.6-16.4%) is more consistent with the NDSHS estimate for the relevant age group (12.3%). This suggests the current findings are not simply a reflection of higher overall reported rates of substance use in the VAHCS sample. We argued that the ongoing participation in the VAHCS for over 20 years may have engendered greater trust and commitment amongst VAHCS respondents, which may have reduced social desirability bias and increased the accuracy with which respondents answered sensitive survey questions [16] . The difference between the current findings from wave 10 of the VAHCS and the NDSHS results do reinforce concerns about the potential impact of the household sampling frame, low response rate and potential social desirability bias in household surveys [1, 7, 8] . The current results may indicate that these biases can be reduced in well-designed longitudinal studies, and suggest further investigation of panel conditioning in this field of research is warranted.
Compared to the previous published report of amphetamine use in the VAHCS when respondents were aged 24 years [24] , the current analysis found a lower level of 12-month use (6.5% vs. 12%) but a greater proportion of frequent use (26% vs. 11%). Over a period of the life course when levels of drug use generally decline [25] , the stability or increasing rates of frequent amphetamine use likely reflects change in the form of drug used [5] tied to a transition to crystal methamphetamine [1] and increased drug purity [26] . These would be expected to increase health, social and personal harms related to use.
Current use was more strongly linked with contemporaneous circumstances (unemployment, multiple disadvantage, relationship, family and living arrangements) than prior use. Polydrug use was also very common [27] , with those currently using amphetamine more likely to report alcohol, illicit drug use and cannabis and alcohol dependence than those who had never used amphetamines. This finding is consistent with existing research. A unique contribution of the current study was to document the role of substance use within the social environment. The finding of more frequent use of amphetamines by adults aged in their mid-30s was most pronounced in persons who reported elevated rates of substance use by their peers and partner.
Current amphetamine use was also associated with mental disorders and mental health service use, a Proportions and associations were estimated using inverse probability weights to account for attrition prior to age 35. Multiple imputation was used to handle missing items within age 35 survey. CI, confidence interval; RRR, relative risk ratio.
although the association with anxiety and service use was largely restricted to frequent users. There was no evidence of this association in the VAHCS 10 years earlier [24] . A comparison of NDSHS data does not show change over time in the association between amphetamine use and mental disorders. The change observed may reflect the intensification of social and economic adversity amongst those using amphetamines at this age. However, it could also be a consequence of more prolonged use, an indication that those with poor mental health were more likely to continue to use the drug, or the effects of the purer form of highly potent crystalline drug that is commonly smoked.
The major strengths of this paper were described earlier and include the study design features, the application of inverse probability weights to adjust for attrition, and the comprehensive breadth of domains assessed. The study also has several limitations. Only a small number of respondents reported using amphetamines frequently, limiting statistical power. While we adjusted for attrition, our weighting approach may not entirely correct for any disproportionate attrition amongst those using amphetamines. Similarly, while we argued that the long-term engagement with the VAHCS may reduce the potential of underreporting due to social desirability bias, stigma or illegality, the current results may still underestimate 'true' rates of amphetamine use in the population. The survey relies on self-report measures and the sampling frame was geographically restricted to the state of Victoria.
The current analysis cannot disentangle age, cohort or period/time effects [28] . The lower levels of current use in this study in comparison to the prior VAHCS wave may reflect a population trend or a change restricted to this cohort. It could also indicate that, over the decade since the prior measurement, many respondents ceased using amphetamines as they matured and their social and economic circumstances became more stable [24] . Earlier disadvantage and poor mental health may have led to continued or new onset of amphetamine use. While the availability of longitudinal data will enable consideration of individual trajectories of amphetamine use over time, such analysis is beyond the scope of the current paper which sought to characterise amphetamine use in contemporary Australia using data from a longitudinal cohort study to provide a different perspective for policy and practice.
In conclusion, we estimate that a substantial proportion of Australians in their mid-30s are currently and frequently using amphetamines. For these individuals, amphetamine use is associated with social disadvantage, limited familial connections, poor mental health and living in a social context in which drug use is the norm.
